Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia258
Hypercoagulability or coronary artery disease? Polygenic risk score unveils the mystery157
Effective treatment of statin- and ezetimibe-resistant hyperlipidemia in a patient with active membranous nephrotic syndrome using a PCSK9 inhibitor122
Assessment of health disparities in secondary ASCVD risk prevention in the elderly population in Greece101
Lipoprotein(a) concentrations across a global cross-sectional registry96
Disparities in statin use among individuals with and without cancer history across atherosclerotic cardiovascular disease risk categories87
Genetic mutations and associated phenotypes in familial hypercholesterolemia: A biobank study82
Care of youth with lipid disorders: A brief provider survey77
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis75
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis68
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse67
The Effect of Estrogen and Testosterone on Cholesterol Crystallization60
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine55
News from NLA47
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database45
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss45
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report44
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease44
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes44
The impact of genetic testing on physician practice in specialized cardiovascular clinics42
Healthcare utilization and expenditures among adults with severe hypertriglyceridemia in US clinical practice40
Exciting new developments in clinical lipidology: Updates from the Food and Drug Administration and the American Heart Association40
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia38
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection36
Inflammation and cardiometabolic disease in South Asians: The fire and fire tenders34
Predictive value of lipoprotein(a) in patients undergoing percutaneous coronary intervention with drug-eluting stent: A meta-analysis34
Lipoprotein lipase DNA methylation in the adipose tissue of patients with persistent chylomicronemia32
Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease32
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study31
Reanalysis of the impact of omega-3 supplementation on lipoprotein-associated phospholipase A2 mass and activity: A systematic review and meta-analysis of randomized controlled trials30
0.09125804901123